Focus on Therapeutics

SESSION 1: Disrupt, Repurpose, Deliver:
The Future Inhaled and Nasal Pipeline

Monday • May 11, 2026 • 10:30–12:00 Noon • Trailblazer’s Ballroom
Moderator: Jayne E. Hastedt, Ph.D.

Therapeutic Landscape Evolution: Technologies Shaping the Future of Pulmonary and Nasal Drug Delivery
Geraldine Venthoye
Independent
Progress in Inhaled Drug Delivery For Non-small Cell Lung Cancer (NSCLC): A Non-invasive Pathway To Targeted Therapy
Nitesh Kunda
St. John's University
Rethinking Metabolic Peptide Delivery: Nasal and Pulmonary Routes for Incretin and Amylin Therapies
Francesca Buttini
University of Parma

Discover More

Translational In Vitro Screening Approach to Support the Development of Dry Powder Inhalation Products by Predicting Clinical Bioavailability
Dina Morais
Hovione
Building Analytical Best Practices for Respiratory Biologics: Raiding the Biological and Respiratory Toolboxes
Mark Parry
Intertek
From Bench to Biologic: A Hands-On Journey to Creating a Dry Powder Inhaler or Nebulizer Product
David Farrow
Aptar Pharma
A Programmable Aerosol Delivery Platform with Multi-Formulation Capability and High Aerosolization Rates
Donovan Yeates
KAER Biotherapeutics
Ondansetron Inhalation Powder: Bioavailability and Safety Results from Phase 1 Clinical Study
Xiaodong Li
Luxena Pharmaceuticals
Medium Chain Length Polyhydroxyalkanoate Nanoparticles for Controlled Drug Delivery to the Lung
Edward Attenborough
Monash University
CC
Inhalation and Systemic Delivery of mRNA to the Lung Using a Stable Lipid Nanoparticle Platform
Cima Cina and Wendy Knowlton
Nitto BioPharma
Evaluation of Metformin Encapsulated Rod-Shaped Iron (III) Carboxylate Biomimetic NanoMetal-Organic Frameworks as Antibacterial Immunotherapy
Aime Fabius Irabin
South Dakota State University
Characterization and Safety of Biomimetic Metal-Organic Frameworks in Macrophages
Joshua Reineke
South Dakota State University
Airway Delivery of circRNA Using Pulmonary-Surfactant-Coated Lipid Nanoparticles for Cystic Fibrosis Gene Therapy
Guizhi (Julian) Zhu
University of Michigan
Inhalable Anti-Inflammatory psLNPs Enable Mucus Penetration and circRNA CFTR Delivery For Cystic Fibrosis Therapy
You Xu and Guizhi (Julian) Zhu
University of Michigan
Direct Aerosol Administration in Preclinical Respiratory Models: Influence of the Parameters of Administration Using the Fine Mist Sprayer
Lucila Garcia-Contreras
University of Oklahoma
Inhalable Liposomal Combination Therapy for the Treatment of Osteosarcoma Lung Metastases
Federica Carnamucio
Virginia Commonwealth University
Pulmonary Delivery of Ginkgetin Attenuates Lung Fibrosis in a Rat Model
Cimone Richardson
Virginia Commonwealth University
Studying the Pharmacodynamic Response of the Tumor Immune Microenvironment in Osteosarcoma Lung Metastases Following Inhaled Gemcitabine Treatment
Victoria Garcia
Virginia Commonwealth University
CONFERENCE SUPPORTERS
↑ Back to Top